Question 1

Does Baker Bros. Advisors own BCRX stock?

Accepted Answer

No. Baker Bros. Advisors exited its BCRX (Biocryst Pharmaceuticals) position in Q1 2026. Its Q4 2025 13F listed 2,822,727 shares worth $22M.

Question 2

How many shares of BCRX does Baker Bros. Advisors own?

Accepted Answer

None since Q1 2026, when Baker Bros. Advisors exited the position. Its Q4 2025 13F listed 2,822,727 shares worth $22M.

Question 3

What is Baker Bros. Advisors' BCRX position worth?

Accepted Answer

Baker Bros. Advisors' BCRX position was worth $22M in its Q4 2025 13F, before the exit in Q1 2026.

Question 4

Is Baker Bros. Advisors buying or selling BCRX?

Accepted Answer

In Q1 2026, Baker Bros. Advisors exited its entire BCRX position.

Question 5

When did Baker Bros. Advisors first buy BCRX?

Accepted Answer

Baker Bros. Advisors already held BCRX in its Q1 2019 13F, the earliest on record, and listed it in 24 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q1 Latest	Exited	0	-100.0%	$0	0.0%	$9.52	0
2025-Q4	New	2.8M	—	$22M	0.1%	$7.80	47
2024-Q4	Exited	0	-100.0%	$0	0.0%	$7.52	0
2024-Q3	Unchanged	75,778	0.0%	$575,913	0.0%	$7.60	0